Fidelity Investments’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Fidelity Investments’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,717	Closed	-$11.5K	–	5712
2023 Q3	$11.5K	Sell	1,717 -16,447	-91%	-$137K	﹤0.01%	4055
2023 Q2	$165K	Buy	18,164 +15,694	+635%	+$138K	﹤0.01%	3004
2023 Q1	$18K	Buy	2,470 +1,528	+162%	+$11.3K	﹤0.01%	3894
2022 Q4	$6.87K	Sell	942 -546	-37%	-$4.05K	﹤0.01%	4148
2022 Q3	$12K	Sell	1,488 -29,578	-95%	-$251K	﹤0.01%	4038
2022 Q2	$212K	Buy	+31,066	New	+$238K	﹤0.01%	3111

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Fidelity Investments's PNT Position: Q4 2023 in Review

Fidelity Investments sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,717 shares — an estimated $11.5K sold.

Fidelity Investments first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $212K in Q2 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Fidelity Investments reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Fidelity Investments sold 1,717 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $11.5K.
Fidelity Investments first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Fidelity Investments's POINT Biopharma Global Inc. Common Stock position peaked at $212K in Q2 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.